Presenter: Ann Livingstone, University of Sydney Ann was recently awarded her PhD. She has a keen interest in patient preferences in trial-based and modelled economic evaluation. In addition, she works as an evaluator for the Australian Medical Services Advisory Committee, reviewing and critiquing evidence to inform government policy decision-making regarding health technologies. Adjuvant immunotherapy has …

Preferences for Adjuvant Immunotherapy in Resected Stage III Melanoma Read More »